#1
#1 out of 1562.0 est. views
politics6h ago
WSJ tears into Trump regulator blocking vital vaccine in scathing takedown
- The Wall Street Journal editorial board denounced Vinay Prasad for rejecting Moderna's flu vaccine, calling it arbitrary.
- editors argued Moderna's trial design was adequate and its vaccine showed higher effectiveness than the standard vaccine.
- Prasad's stance was framed as harming vaccine access and dampening FDA morale, according to the WSJ board.
- The WSJ asked whether the White House is paying attention as public sentiment around vaccine mandates remains mixed.
- The Raw Story piece notes prior scrutiny of Prasad by Laura Loomer and subsequent return to his FDA role.
Vote 0